Search research articles
Contact Us
Filters
Showing results (81-90 of 116) with videos related to
Page
of 12
Sort By:
The Lancet. Oncology
|
July 17, 2023
Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study
Reinhard Dummer, Paola Queirolo, Pauline Gerard Duhard, et al.
The Lancet. Oncology
|
August 8, 2022
Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study
Reinhard Dummer, Paola Queirolo, Ana Maria Abajo Guijarro, et al.
International Journal of Molecular Sciences
|
March 11, 2023
Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting
Irene Vanni, Lorenza Pastorino, Enrica Teresa Tanda, et al.
Journal of Neuro-Oncology
|
February 18, 2014
Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases
Paola Queirolo, Francesco Spagnolo, Paolo Antonio Ascierto, et al.
Oncology Letters
|
April 14, 2016
Sun exposure and melanoma prognostic factors
Sara Gandini, Maurizio Montella, Fabrizio Ayala, et al.
The Oncologist
|
December 21, 2023
Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go?
Salvatore Alfieri, Rebecca Romanò, Sara Marceglia, et al.
Cancer Treatment and Research Communications
|
September 1, 2024
Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients
Francesca Parisi, Giuseppa De Luca, Manuela Mosconi, et al.
Cancers
|
February 3, 2021
No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study
Michele Guida, Nicola Bartolomeo, Pietro Quaglino, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 18, 2021
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma
Alice Baggi, Pietro Quaglino, Marco Rubatto, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 7, 2023
Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profile
Paolo A Ascierto, Anna M Di Giacomo, Vanna Chiarion Sileni, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 116) with videos related to
Sort By:
Page
of 12
The Lancet. Oncology
|
July 17, 2023
Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study
Reinhard Dummer, Paola Queirolo, Pauline Gerard Duhard, et al.
The Lancet. Oncology
|
August 8, 2022
Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study
Reinhard Dummer, Paola Queirolo, Ana Maria Abajo Guijarro, et al.
International Journal of Molecular Sciences
|
March 11, 2023
Whole-Exome Sequencing and cfDNA Analysis Uncover Genetic Determinants of Melanoma Therapy Response in a Real-World Setting
Irene Vanni, Lorenza Pastorino, Enrica Teresa Tanda, et al.
Journal of Neuro-Oncology
|
February 18, 2014
Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases
Paola Queirolo, Francesco Spagnolo, Paolo Antonio Ascierto, et al.
Oncology Letters
|
April 14, 2016
Sun exposure and melanoma prognostic factors
Sara Gandini, Maurizio Montella, Fabrizio Ayala, et al.
The Oncologist
|
December 21, 2023
Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go?
Salvatore Alfieri, Rebecca Romanò, Sara Marceglia, et al.
Cancer Treatment and Research Communications
|
September 1, 2024
Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients
Francesca Parisi, Giuseppa De Luca, Manuela Mosconi, et al.
Cancers
|
February 3, 2021
No Impact of NRAS Mutation on Features of Primary and Metastatic Melanoma or on Outcomes of Checkpoint Inhibitor Immunotherapy: An Italian Melanoma Intergroup (IMI) Study
Michele Guida, Nicola Bartolomeo, Pietro Quaglino, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 18, 2021
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinoma
Alice Baggi, Pietro Quaglino, Marco Rubatto, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 7, 2023
Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profile
Paolo A Ascierto, Anna M Di Giacomo, Vanna Chiarion Sileni, et al.
Page
of 12